Nanomedicines continue to accelerate the forefront of drug delivery technologies. Inorganic mesoporous silica nanoparticles are a driving force with their unique and superlative properties. Recently, formulation researches with mesoporous silica nanoparticles have advanced many drug delivery systems, including liposome, microsphere, oro-dispersible film, 3D-printed formulation, and microneedle. 

Dipy Vasa from Pfizer focuses this talk on mesoporus silica solubility-enabling technology background and examples, her teams current work, experimental setup, controlling drug release with HPMCAS and potential applications to this approach.

FREE WEBINAR: Tuning Drug Release from Mesoporus Silica Particles: Impact of HPMCAS Polymer

Dipy Vasa, PhD
  • LinkedIn
  • Twitter
  • Google+
  • Facebook
  • Pinterest
  • Print Friendly

Dipy Vasa, PhD

Senior Scientist, Drug Product Design

Pfizer

2023 Global Drug Bioavailability Enhancement Summit

(May 16-17, 2023, Princeton, NJ)

 

Interested to improve the performance of your drug products? Learn 2 years of new drug product development approaches at the 2023 Summit this coming May both in-person & virtual.

Join 160+ leading drug delivery, formulation and development experts and hear 30+ expert sessions. Gain over 2 years worth of new drug product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 short days (all available on-demand)!

Save up-to 50% on attendance before Friday 28th October, 2022. Likewise, have a platform technology you would like to explore showcasing to the wider audience this May? Reach out below to find out remaining opportunities.

2021 On-Demand Summits Available for Purchase

(Limited time - Only $299)

Pin It on Pinterest

Share This

Share this with a friend or colleague!